skip to Main Content

A novel CDKN2A in-frame deletion associated with pancreatic cancer-melanoma syndrome

A novel CDKN2A in-frame deletion associated with pancreatic cancer-melanoma syndrome
Pancreatic cancer-melanoma syndrome (PCMS) is an inherited condition in which mutation carriers have an increased risk of malignant melanoma and/or pancreatic cancer. About 30% of PCMS cases carry mutations in CDKN2A.

This gene encodes several protein isoforms, one of which, known as p16, regulates the cell-cycle by interacting with CDK4/CDK6 kinases and with several non-CDK proteins. Herein, we report on a novel CDKN2A germline in-frame deletion (c.52_57delACGGCC) found in an Italian family with PMS. Read more . . . 


Back To Top